1.43
전일 마감가:
$1.39
열려 있는:
$1.41
하루 거래량:
331.39K
Relative Volume:
0.44
시가총액:
$44.84M
수익:
-
순이익/손실:
$-69.00M
주가수익비율:
-0.5144
EPS:
-2.78
순현금흐름:
$-55.26M
1주 성능:
+5.93%
1개월 성능:
+7.52%
6개월 성능:
-73.76%
1년 성능:
-82.92%
Acrivon Therapeutics Inc Stock (ACRV) Company Profile
명칭
Acrivon Therapeutics Inc
전화
617-207-8979
주소
480 ARSENAL WAY, SUITE 100, WATERTOWN
ACRV을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
ACRV
Acrivon Therapeutics Inc
|
1.43 | 43.58M | 0 | -69.00M | -55.26M | -2.78 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Acrivon Therapeutics Inc Stock (ACRV) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-05-05 | 재개 | Piper Sandler | Overweight |
2025-01-31 | 개시 | KeyBanc Capital Markets | Overweight |
2024-09-16 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
2024-04-29 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
2024-03-01 | 개시 | JMP Securities | Mkt Outperform |
2023-12-15 | 재개 | Jefferies | Buy |
2023-10-05 | 개시 | Maxim Group | Buy |
2023-06-02 | 개시 | Oppenheimer | Outperform |
2023-05-08 | 개시 | BMO Capital Markets | Outperform |
2023-04-27 | 개시 | Ladenburg Thalmann | Buy |
2023-04-20 | 개시 | H.C. Wainwright | Buy |
2022-12-12 | 개시 | Cowen | Outperform |
2022-12-12 | 개시 | Jefferies | Buy |
2022-12-12 | 개시 | Piper Sandler | Overweight |
모두보기
Acrivon Therapeutics Inc 주식(ACRV)의 최신 뉴스
Is Acrivon Therapeutics Inc. stock a good hedge against inflationPotential Rocket List - Newser
What is the dividend policy of Acrivon Therapeutics Inc. stockGet timely market insights for better trades - jammulinksnews.com
How high can Acrivon Therapeutics Inc. stock price go in 2025Free Group Entry - Newser
Acrivon Therapeutics Inc. Stock Analysis and ForecastAccelerated earnings growth - jammulinksnews.com
What analysts say about Acrivon Therapeutics Inc. stockRapid wealth creation - jammulinksnews.com
Is Acrivon Therapeutics Inc. a good long term investmentHigh-octane investment gains - jammulinksnews.com
Here's Why We're Watching Acrivon Therapeutics' (NASDAQ:ACRV) Cash Burn Situation - Yahoo Finance
What drives Acrivon Therapeutics Inc. stock priceHigh-profit capital plays - jammulinksnews.com
Why Acrivon Therapeutics Inc. stock attracts strong analyst attentionFree Insider Trading Tips - beatles.ru
Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Receives Average Rating of “Buy” from Analysts - Defense World
Analysts Set Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Target Price at $17.71 - Defense World
What makes Acrivon Therapeutics Inc. stock price move sharplyFree Stock Market Real-Time Monitoring - Newser
Cantor Fitzgerald sets Acrivon stock to Overweight on AP3 platform - MSN
How Acrivon Therapeutics Inc. stock performs during market volatilityAlpha Stock Ideas - Newser
Endometrial Cancer Clinical Trial Pipeline Insights: 50+ Companies Shaping Future Treatment Paradigms | DelveInsight - GlobeNewswire Inc.
(ACRV) Investment Analysis and Advice - news.stocktradersdaily.com
Acrivon Therapeutics (NASDAQ:ACRV) Trading 0.7% Higher – Still a Buy? - Defense World
Acrivon Therapeutics, Inc.(NasdaqGM: ACRV) dropped from S&P Global BMI Index - MarketScreener
Learn to Evaluate (ACRV) using the Charts - news.stocktradersdaily.com
Acrivon Therapeutics Holds Annual Stockholders Meeting - TipRanks
Analysts Offer Predictions for ACRV FY2026 Earnings - Defense World
Long Term Trading Analysis for (ACRV) - news.stocktradersdaily.com
Acrivon Therapeutics Inc (ACRV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Acrivon Therapeutics Inc 주식 (ACRV) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
PERCEPTIVE ADVISORS LLC | 10% Owner |
May 01 '25 |
Sale |
1.34 |
298,886 |
400,507 |
3,104,139 |
PERCEPTIVE ADVISORS LLC | 10% Owner |
Apr 25 '25 |
Sale |
1.95 |
1,054,669 |
2,056,605 |
4,306,189 |
PERCEPTIVE ADVISORS LLC | 10% Owner |
Apr 29 '25 |
Sale |
1.41 |
250,000 |
352,500 |
3,840,906 |
PERCEPTIVE ADVISORS LLC | 10% Owner |
Apr 28 '25 |
Sale |
1.56 |
215,283 |
335,841 |
4,090,906 |
자본화:
|
볼륨(24시간):